INTRODUCTION: Recent studies in the human adenocarcinoma cell line A549 have identified cell growth-dependent equilibrative nucleoside transporter-1 (hENT1) as a modifier of 3'-fluoro-3'-deoxythymidine (FLT) uptake and retention. In the present study, we used the ability to isolate human lymphoblastoid clones deficient in thymidine kinase 1 (TK1) to study how metabolism and nucleoside transport influence FLT uptake and retention. METHODS: Transport and metabolism of FLT were measured in the human lymphoblastoid cell line TK6 and in eight clones isolated from TK6. Four clones were TK1-proficient, while four were TK1-deficient. Both influx and efflux of FLT were measured under conditions where concentrative and equilibrative transport could be distinguished. RESULTS: Sodium-dependent concentrative FLT transport dominated over equilibrative transport mechanisms and while inhibition of hENT1 reduced FLT uptake, there were no correlations between clonal variations in hENT1 levels and FLT uptake. There was an absolute requirement of TK1 for concentration of FLT in TK6 cells. FLT uptake reached a peak after 60 min of incubation with FLT after which intracellular levels of FLT and FLT metabolites declined. Efflux was rapid and was associated with reductions in FLT and each of its metabolites. Both FLT and FLT-monophosphate were found in the efflux buffer. CONCLUSIONS: Initial rates of FLT uptake were a function of both concentrative and equilibrative transporters. TK1 activity was an absolute requirement for the accumulation of FLT. Retention was dependent on nucleoside/nucleotide efflux and retrograde metabolism of FLT nucleotides. Published by Elsevier Inc.
INTRODUCTION: Recent studies in the humanadenocarcinoma cell line A549 have identified cell growth-dependent equilibrative nucleoside transporter-1 (hENT1) as a modifier of 3'-fluoro-3'-deoxythymidine (FLT) uptake and retention. In the present study, we used the ability to isolate human lymphoblastoid clones deficient in thymidine kinase 1 (TK1) to study how metabolism and nucleoside transport influence FLT uptake and retention. METHODS: Transport and metabolism of FLT were measured in the human lymphoblastoid cell line TK6 and in eight clones isolated from TK6. Four clones were TK1-proficient, while four were TK1-deficient. Both influx and efflux of FLT were measured under conditions where concentrative and equilibrative transport could be distinguished. RESULTS:Sodium-dependent concentrative FLT transport dominated over equilibrative transport mechanisms and while inhibition of hENT1 reduced FLT uptake, there were no correlations between clonal variations in hENT1 levels and FLT uptake. There was an absolute requirement of TK1 for concentration of FLT in TK6 cells. FLT uptake reached a peak after 60 min of incubation with FLT after which intracellular levels of FLT and FLT metabolites declined. Efflux was rapid and was associated with reductions in FLT and each of its metabolites. Both FLT and FLT-monophosphate were found in the efflux buffer. CONCLUSIONS: Initial rates of FLT uptake were a function of both concentrative and equilibrative transporters. TK1 activity was an absolute requirement for the accumulation of FLT. Retention was dependent on nucleoside/nucleotide efflux and retrograde metabolism of FLT nucleotides. Published by Elsevier Inc.
Authors: David A Plotnik; Lindsay E Emerick; Kenneth A Krohn; Jashvant D Unadkat; Jeffrey L Schwartz Journal: J Nucl Med Date: 2010-08-18 Impact factor: 10.057
Authors: C L van der Wilt; H H Backus; K Smid; L Comijn; G Veerman; D Wouters; D A Voorn; D G Priest; M A Bunni; F Mitchell; A L Jackman; G Jansen; G J Peters Journal: Cancer Res Date: 2001-05-01 Impact factor: 12.701
Authors: C E Cass; J D Young; S A Baldwin; M A Cabrita; K A Graham; M Griffiths; L L Jennings; J R Mackey; A M Ng; M W Ritzel; M F Vickers; S Y Yao Journal: Pharm Biotechnol Date: 1999
Authors: C Soler; J García-Manteiga; R Valdés; J Xaus; M Comalada; F J Casado; M Pastor-Anglada; A Celada; A Felipe Journal: FASEB J Date: 2001-09 Impact factor: 5.191
Authors: M Peck; H A Pollack; A Friesen; M Muzi; S C Shoner; E G Shankland; J R Fink; J O Armstrong; J M Link; K A Krohn Journal: Q J Nucl Med Mol Imaging Date: 2015-03-04 Impact factor: 2.346
Authors: Keke Liang; Evan R Abt; Thuc M Le; Arthur Cho; Amanda M Dann; Jing Cui; Luyi Li; Khalid Rashid; Amanda L Creech; Liu Wei; Razmik Ghukasyan; Ethan W Rosser; Nanping Wu; Giuseppe Carlucci; Johannes Czernin; Timothy R Donahue; Caius G Radu Journal: Proc Natl Acad Sci U S A Date: 2021-09-07 Impact factor: 11.205
Authors: Laura L Boles Ponto; Susan Walsh; Jiangeng Huang; Christine Mundt; Katherine Thede-Reynolds; G Leonard Watkins; John Sunderland; Michael Acevedo; Maureen Donovan Journal: AAPS J Date: 2017-12-07 Impact factor: 4.009
Authors: Lars Stelter; Simon Fuchs; Achim A Jungbluth; Gerd Ritter; Valerie A Longo; Pat Zanzonico; Nathanael Raschzok; Igor M Sauer; John S Bomalaski; Steven M Larson Journal: Mol Imaging Biol Date: 2013-12 Impact factor: 3.488
Authors: David A Plotnik; Stephen Wu; Geoffrey R Linn; Franco Chi Tat Yip; Natacha Lou Comandante; Kenneth A Krohn; Jun Toyohara; Jeffrey L Schwartz Journal: Nucl Med Biol Date: 2014-12-06 Impact factor: 2.408
Authors: Valerie Carroll; Brian W Michel; Joseph Blecha; Henry VanBrocklin; Kayvan Keshari; David Wilson; Christopher J Chang Journal: J Am Chem Soc Date: 2014-10-13 Impact factor: 15.419
Authors: Peter J O'Brien; Michelle Lee; Mary E Spilker; Cathy C Zhang; Zhengming Yan; Timothy C Nichols; Wenlin Li; Caroline H Johnson; Gary J Patti; Gary Siuzdak Journal: Cancer Metab Date: 2013-01-23